GUPEA >
Sahlgrenska Academy / Sahlgrenska akademin >
Institute of Clinical Sciences / Institutionen för kliniska vetenskaper >
Doctoral Theses / Doktorsavhandlingar Institutionen för kliniska vetenskaper >

Characteristics of screen-failures in prostate cancer screening


Please use this identifier to cite or link to this item: http://hdl.handle.net/2077/38003

Files in This Item:

File Description SizeFormat
gupea_2077_38003_1.pdfThesis frame2751KbAdobe PDF
View/Open
gupea_2077_38003_3.pdfAbstract254KbAdobe PDF
View/Open
Title: Characteristics of screen-failures in prostate cancer screening
Authors: Grenabo Bergdahl, Anna
E-mail: anna.grenabo@vgregion.se
Issue Date: 30-Mar-2015
University: University of Gothenburg. Sahlgrenska Academy
Institution: Institute of Clincial Sciences. Department of Urology
Parts of work: I. Roobol M, Grenabo A et al. Interval cancers in prostate cancer screening: comparing 2- and 4- year screening intervals in the European Randomised Study of Screening for Prostate Cancer, Gothenburg and Rotterdam. J Natl Cancer Inst 2007; 99: 1296-303
VIEW ARTICLE


II. Grenabo Bergdahl A, Aus G et al. Risk of dying from prostate cancer in men randomised to screening: differences between attendees and nonattendees. Cancer 2009; 115: 5672-9
VIEW ARTICLE


III. Grenabo Bergdahl A, Holmber E et al. Incidence of prostate cancer after termination of screening in a population-based randomised screening trial. Eur Urol 2013; 64: 703-9
VIEW ARTICLE


IV. Grenabo Bergdahl A, Wilderäng U et al. Role fo MRI in prostate cancer screening: results from a pilot study nested within the Göteborg randomized screening trial (manuscript)
Date of Defence: 2015-04-17
Disputation: Fredagen den 17 april 2015, kl. 9.00, Hörsal Arvid Carlsson, Academicum, Medicinaregatan 3.
Degree: Doctor of Philosophy (Medicine)
Publication type: Doctoral thesis
Keywords: screening
prostate cancer
screening failures
antigen
age
interval cancer
multiparametric magnetic resonance imaging
non-attendees
prostate cancer screening
Abstract: ABSTRACT Although prostate-specific antigen (PSA)-based screening has been shown to reduce prostate cancer (PC)-specific mortality with large variations in mortality reduction with different screening algorithms, the optimal screening strategy has not yet been established. This thesis aims at exploring aspects of underdiagnosis in PC screening, focusing on the impact of screening failures on screening effectiveness. All of its papers are based on the Göteborg randomized PC screening trial excep... more
ISBN: 978-91-628-9331-6
978-91-628-9330-9 (printed edition)
URI: http://hdl.handle.net/2077/38003
Appears in Collections:Doctoral Theses from Sahlgrenska Academy
Doctoral Theses from University of Gothenburg / Doktorsavhandlingar från Göteborgs universitet
Doctoral Theses / Doktorsavhandlingar Institutionen för kliniska vetenskaper

 

 

© Göteborgs universitet 2011